TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10931468
log Bayes Factor = 0.155646
Chromosome 2   position 191,538,562  (GRCh37) Explore rs10931468 on Ensembl!
Variant rs10931468 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.753 0.247
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.755 0.245
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.764 0.236
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.766 0.234
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.768 0.232
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.772 0.228
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.779 0.221
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.793 0.207
T42.4 Benzodiazepines
0.000 0.794 0.206
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.796 0.204
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.798 0.202
T43.2 Other and unspecified antidepressants
0.000 0.799 0.201
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.799 0.201
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.799 0.200
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.801 0.199
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.808 0.192
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.811 0.189
T42.1 Iminostilbenes
0.000 0.812 0.187
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.812 0.188
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.814 0.186
T46.1 Calcium-channel blockers
0.000 0.817 0.183
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.820 0.180
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.822 0.177
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.822 0.177
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.822 0.177
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.822 0.177
T43.9 Psychotropic drug, unspecified
0.000 0.824 0.176
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.824 0.176
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.824 0.176
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.824 0.176
T36 Poisoning by systemic antibiotics
0.000 0.825 0.174
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.826 0.174
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.832 0.168
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.832 0.168
T42.3 Barbiturates
0.000 0.832 0.168
T42.2 Succinimides and oxazolidinediones
0.000 0.832 0.168
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.833 0.167
T50.8 Diagnostic agents
0.000 0.834 0.166
T50.7 Analeptics and opioid receptor antagonists
0.000 0.834 0.166
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.834 0.166
T50.5 Appetite depressants
0.000 0.834 0.166
T50.4 Drugs affecting uric acid metabolism
0.000 0.834 0.166
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.834 0.166
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.834 0.166
T50.1 Loop [high-ceiling] diuretics
0.000 0.834 0.166
T50.0 Mineralocorticoids and their antagonists
0.000 0.834 0.166
T40.2 Other opioids
0.000 0.835 0.165
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.836 0.164
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.836 0.164
T46.7 Peripheral vasodilators
0.000 0.836 0.164
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.836 0.164
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.836 0.164
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.836 0.164
T45.0 Antiallergic and antiemetic drugs
0.000 0.838 0.162
T40.6 Other and unspecified narcotics
0.000 0.841 0.159
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.848 0.152
T42.0 Hydantoin derivatives
0.000 0.849 0.151
T43.6 Psychostimulants with abuse potential
0.000 0.852 0.148
T39.1 4-Aminophenol derivatives
0.000 0.852 0.148
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.854 0.146
T39.4 Antirheumatics, not elsewhere classified
0.000 0.854 0.146
T39.2 Pyrazolone derivatives
0.000 0.854 0.146
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.855 0.145
T40.8 Lysergide [LSD]
0.000 0.855 0.145
T40.7 Cannabis (derivatives)
0.000 0.855 0.145
T40.5 Cocaine
0.000 0.855 0.145
T40.3 Methadone
0.000 0.855 0.145
T40.1 Heroin
0.000 0.855 0.145
T40.0 Opium
0.000 0.855 0.145
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.856 0.144
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.856 0.144
T47.7 Emetics
0.000 0.856 0.144
T47.6 Antidiarrhoeal drugs
0.000 0.856 0.144
T47.5 Digestants
0.000 0.856 0.144
T47.4 Other laxatives
0.000 0.856 0.144
T47.3 Saline and osmotic laxatives
0.000 0.856 0.144
T47.2 Stimulant laxatives
0.000 0.856 0.144
T47.0 Histamine H(2)-receptor antagonists
0.000 0.856 0.144
T40.4 Other synthetic narcotics
0.000 0.864 0.135
T45.5 Anticoagulants
0.000 0.865 0.135
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.866 0.133
T45.8 Other primarily systemic and haematological agents
0.000 0.866 0.133
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.866 0.133
T45.6 Fibrinolysis-affecting drugs
0.000 0.866 0.133
T45.4 Iron and its compounds
0.000 0.866 0.133
T45.3 Enzymes, not elsewhere classified
0.000 0.866 0.133
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.869 0.131
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.871 0.129
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.872 0.127
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.872 0.127
T37.5 Antiviral drugs
0.000 0.872 0.127
T37.4 Anthelminthics
0.000 0.872 0.127
T37.3 Other antiprotozoal drugs
0.000 0.872 0.127
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.872 0.127
T37.1 Antimycobacterial drugs
0.000 0.872 0.127
T37.0 Sulphonamides
0.000 0.872 0.127
T41.5 Therapeutic gases
0.000 0.872 0.127
T41.4 Anaesthetic, unspecified
0.000 0.872 0.127
T41.3 Local anaesthetics
0.000 0.872 0.127
T41.2 Other and unspecified general anaesthetics
0.000 0.872 0.127
T41.1 Intravenous anaesthetics
0.000 0.872 0.127
T41.0 Inhaled anaesthetics
0.000 0.872 0.127
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.872 0.127
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.872 0.127
T48.5 Anti-common-cold drugs
0.000 0.872 0.127
T48.4 Expectorants
0.000 0.872 0.127
T48.3 Antitussives
0.000 0.872 0.127
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.872 0.127
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.872 0.127
T48.0 Oxytocic drugs
0.000 0.872 0.127
T49.9 Topical agent, unspecified
0.000 0.872 0.127
T49.8 Other topical agents
0.000 0.872 0.127
T49.7 Dental drugs, topically applied
0.000 0.872 0.127
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.872 0.127
T49.5 Ophthalmological drugs and preparations
0.000 0.872 0.127
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.872 0.127
T49.3 Emollients, demulcents and protectants
0.000 0.872 0.127
T49.2 Local astringents and local detergents
0.000 0.872 0.127
T49.1 Antipruritics
0.000 0.872 0.127
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.872 0.127
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.874 0.126
T36.9 Systemic antibiotic, unspecified
0.000 0.875 0.125
T36.8 Other systemic antibiotics
0.000 0.875 0.125
T36.7 Antifungal antibiotics, systemically used
0.000 0.875 0.125
T36.6 Rifamycins
0.000 0.875 0.125
T36.5 Aminoglycosides
0.000 0.875 0.125
T36.4 Tetracyclines
0.000 0.875 0.125
T36.3 Macrolides
0.000 0.875 0.125
T36.2 Chloramphenicol group
0.000 0.875 0.125
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.875 0.125
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.875 0.125
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.875 0.125
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.875 0.125
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.875 0.125
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.875 0.125
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.875 0.125
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.875 0.125
T44.0 Anticholinesterase agents
0.000 0.875 0.125
T36.0 Penicillins
0.000 0.878 0.122
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.121 0.879 0.000
C85.1 B-cell lymphoma, unspecified
0.120 0.880 0.000
T39.0 Salicylates
0.000 0.881 0.119
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.886 0.114
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.886 0.114
T45.2 Vitamins, not elsewhere classified
0.000 0.886 0.114
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.113 0.887 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.112 0.888 0.000
C81 Hodgkin's disease
0.107 0.893 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.105 0.895 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.103 0.897 0.000
C83.3 Large cell (diffuse)
0.100 0.900 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.097 0.903 0.000
C81.1 Nodular sclerosis
0.095 0.905 0.000
C81.9 Hodgkin's disease, unspecified
0.093 0.907 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.092 0.908 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.909 0.090
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.909 0.090
T38.7 Androgens and anabolic congeners
0.000 0.909 0.090
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.909 0.090
T38.5 Other oestrogens and progestogens
0.000 0.909 0.090
T38.4 Oral contraceptives
0.000 0.909 0.090
T38.2 Antithyroid drugs
0.000 0.909 0.090
T38.0 Glucocorticoids and synthetic analogues
0.000 0.909 0.090
C83.0 Small cell (diffuse)
0.090 0.909 0.000
C82.2 Large cell, follicular
0.087 0.913 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.087 0.913 0.000
C85.0 Lymphosarcoma
0.087 0.913 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.085 0.915 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.915 0.084
C95 Leukaemia of unspecified cell type
0.084 0.916 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.081 0.919 0.000
C94 Other leukaemias of specified cell type
0.081 0.919 0.000
C93 Monocytic leukaemia
0.081 0.919 0.000
C86 Other specified types of T/NK-cell lymphoma
0.081 0.919 0.000
C83.7 Burkitt's tumour
0.081 0.919 0.000
C88 Malignant immunoproliferative diseases
0.081 0.919 0.000
C90.2 Plasmacytoma, extramedullary
0.080 0.920 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.078 0.922 0.000
C90.3 Solitary plasmacytoma
0.078 0.922 0.000
C81.7 Other Hodgkin's disease
0.076 0.923 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.076 0.923 0.000
C81.3 Lymphocytic depletion
0.076 0.923 0.000
C81.2 Mixed cellularity
0.076 0.923 0.000
C81.0 Lymphocytic predominance
0.076 0.923 0.000
C82.0 Small cleaved cell, follicular
0.076 0.924 0.000
C83.6 Undifferentiated (diffuse)
0.076 0.924 0.000
C83.5 Lymphoblastic (diffuse)
0.076 0.924 0.000
C83.4 Immunoblastic (diffuse)
0.076 0.924 0.000
C83.2 Mixed small and large cell (diffuse)
0.076 0.924 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.075 0.925 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.074 0.926 0.000
C82.6 Cutaneous follicle centre lymphoma
0.074 0.926 0.000
C82.5 Diffuse follicle centre lymphoma
0.074 0.926 0.000
C82.4 Follicular lymphoma grade IIIb
0.074 0.926 0.000
C82.3 Follicular lymphoma grade IIIa
0.074 0.926 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.072 0.928 0.000
C83.1 Small cleaved cell (diffuse)
0.067 0.933 0.000
C90.1 Plasma cell leukaemia
0.066 0.933 0.000
C91 Lymphoid leukaemia
0.066 0.934 0.000
C95.9 Leukaemia, unspecified
0.063 0.937 0.000
C95.7 Other leukaemia of unspecified cell type
0.060 0.940 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.060 0.940 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.060 0.940 0.000
C95.0 Acute leukaemia of unspecified cell type
0.060 0.940 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.059 0.941 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.058 0.941 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.058 0.941 0.000
C86.4 Blastic NK-cell lymphoma
0.058 0.941 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.058 0.941 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.058 0.941 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.058 0.941 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.058 0.941 0.000
C93.9 Monocytic leukaemia, unspecified
0.058 0.941 0.000
C93.7 Other monocytic leukaemia
0.058 0.941 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.058 0.941 0.000
C93.2 Subacute monocytic leukaemia
0.058 0.941 0.000
C93.1 Chronic monocytic leukaemia
0.058 0.941 0.000
C93.0 Acute monocytic leukaemia
0.058 0.941 0.000
C94.7 Other specified leukaemias
0.058 0.941 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.058 0.941 0.000
C94.5 Acute myelofibrosis
0.058 0.941 0.000
C94.4 Acute panmyelosis
0.058 0.941 0.000
C94.3 Mast cell leukaemia
0.058 0.941 0.000
C94.2 Acute megakaryoblastic leukaemia
0.058 0.941 0.000
C94.1 Chronic erythraemia
0.058 0.941 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.058 0.941 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.058 0.941 0.000
C96.8 Histiocytic sarcoma
0.058 0.941 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.058 0.941 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.058 0.941 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.058 0.941 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.058 0.941 0.000
C96.3 True histiocytic lymphoma
0.058 0.941 0.000
C96.2 Malignant mast cell tumour
0.058 0.941 0.000
C96.1 Malignant histiocytosis
0.058 0.941 0.000
C96.0 Letterer-Siwe disease
0.058 0.941 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.058 0.942 0.000
C88.7 Other malignant immunoproliferative diseases
0.058 0.942 0.000
C88.3 Immunoproliferative small intestinal disease
0.058 0.942 0.000
C88.2 Gamma heavy chain disease
0.058 0.942 0.000
C88.1 Alpha heavy chain disease
0.058 0.942 0.000
C91.9 Lymphoid leukaemia, unspecified
0.056 0.943 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.056 0.944 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.948 0.051
C84.9 Mature T/NK-cell lymphoma, unspecified
0.052 0.948 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.052 0.948 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.052 0.948 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.052 0.948 0.000
C84.3 Lymphoepithelioid lymphoma
0.052 0.948 0.000
C84.2 T-zone lymphoma
0.052 0.948 0.000
C84.1 Sezary's diease
0.052 0.948 0.000
C84.0 Mycosis fungoides
0.052 0.948 0.000
C91.0 Acute lymphoblastic leukaemia
0.052 0.948 0.000
C84.4 Peripheral T-cell lymphoma
0.048 0.951 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.048 0.952 0.000
C91.7 Other lymphoid leukaemia
0.048 0.952 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.048 0.952 0.000
C91.5 Adult T-cell leukaemia
0.048 0.952 0.000
C91.3 Prolymphocytic leukaemia
0.048 0.952 0.000
C91.2 Subacute lymphocytic leukaemia
0.048 0.952 0.000
C84.5 Other and unspecified T-cell lymphomas
0.046 0.953 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.046 0.953 0.000
C92 Myeloid leukaemia
0.039 0.960 0.001
C90.0 Multiple myeloma
0.037 0.963 0.000
C91.4 Hairy-cell leukaemia
0.035 0.964 0.000
C92.4 Acute promyelocytic leukaemia
0.029 0.970 0.001
C92.9 Myeloid leukaemia, unspecified
0.028 0.971 0.001
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.028 0.971 0.001
C92.7 Other myeloid leukaemia
0.028 0.971 0.001
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.028 0.971 0.001
C92.5 Acute myelomonocytic leukaemia
0.028 0.971 0.001
C92.3 Myeloid sarcoma
0.028 0.971 0.001
C92.2 Subacute myeloid leukaemia
0.028 0.971 0.001
C50.3 Lower-inner quadrant of breast
0.022 0.978 0.000
C92.1 Chronic myeloid leukaemia
0.019 0.980 0.001
N18.4 Chronic kidney disease, stage 4
0.020 0.980 0.000
C91.1 Chronic lymphocytic leukaemia
0.018 0.982 0.000
F10.3 Withdrawal state
0.000 0.983 0.017
N19 Unspecified renal failure
0.017 0.983 0.000
F10.2 Dependence syndrome
0.000 0.985 0.015
N18 Chronic renal failure
0.014 0.986 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.000 0.986 0.014
N17-N19 Renal failure
0.013 0.987 0.000
N18.5 Chronic kidney disease, stage 5
0.013 0.987 0.000
N18.0 End-stage renal disease
0.012 0.988 0.000
F10.4 Withdrawal state with delirium
0.000 0.988 0.011
F10.9 Unspecified mental and behavioural disorder
0.000 0.989 0.011
N18.1 Chronic kidney disease, stage 1
0.010 0.989 0.000
C50 Malignant neoplasm of breast
0.010 0.990 0.000
F10.8 Other mental and behavioural disorders
0.000 0.990 0.010
F10.7 Residual and late-onset psychotic disorder
0.000 0.990 0.010
F10.6 Amnesic syndrome
0.000 0.990 0.010
C50.1 Central portion of breast
0.010 0.990 0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly
0.010 0.990 0.000
C50.4 Upper-outer quadrant of breast
0.010 0.990 0.000
F10.5 Psychotic disorder
0.000 0.991 0.009
N18.8 Other chronic renal failure
0.009 0.991 0.000
C92.0 Acute myeloid leukaemia
0.007 0.991 0.002
T51.0 Ethanol
0.000 0.991 0.009
Z34.8 Supervision of other normal pregnancy
0.008 0.992 0.000
N18.9 Chronic renal failure, unspecified
0.008 0.992 0.000
Y95 Nosocomial condition
0.008 0.992 0.000
M20.4 Other hammer toe(s) (acquired)
0.008 0.992 0.000
N17 Acute renal failure
0.008 0.992 0.000
N18.2 Chronic kidney disease, stage 2
0.007 0.992 0.000
C50.6 Axillary tail of breast
0.007 0.993 0.000
C50.2 Upper-inner quadrant of breast
0.007 0.993 0.000
F99 Mental disorder, not otherwise specified
0.000 0.993 0.007
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.000 0.993 0.007
F33.1 Recurrent depressive disorder, current episode moderate
0.000 0.993 0.007
K60.1 Chronic anal fissure
0.007 0.993 0.000
K60.0 Acute anal fissure
0.007 0.993 0.000
F33 Recurrent depressive disorder
0.000 0.994 0.006
F99-F99 Unspecified mental disorder
0.000 0.994 0.006
F30-F39 Mood [affective] disorders
0.000 0.994 0.006
C50.5 Lower-outer quadrant of breast
0.006 0.994 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.994 0.006
D69.3 Idiopathic thrombocytopenic purpura
0.006 0.994 0.000
F31 Bipolar affective disorder
0.000 0.994 0.006
Chapter V Mental and behavioural disorders
0.000 0.994 0.006
N17.0 Acute renal failure with tubular necrosis
0.006 0.994 0.000
N17.8 Other acute renal failure
0.006 0.994 0.000
N17.2 Acute renal failure with medullary necrosis
0.006 0.994 0.000
N17.1 Acute renal failure with acute cortical necrosis
0.006 0.994 0.000
D69.6 Thrombocytopenia, unspecified
0.006 0.994 0.000
C50-C50 Malignant neoplasm of breast
0.005 0.995 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.995 0.005
M25.46 Effusion of joint (Lower leg)
0.000 0.995 0.005
F18 Mental and behavioural disorders due to use of volatile solvents
0.000 0.995 0.005
F16 Mental and behavioural disorders due to use of hallucinogens
0.000 0.995 0.005
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.000 0.995 0.005
F14 Mental and behavioural disorders due to use of cocaine
0.000 0.995 0.005
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.000 0.995 0.005
K60 Fissure and fistula of anal and rectal regions
0.005 0.995 0.000
F32 Depressive episode
0.000 0.995 0.005
F31.6 Bipolar affective disorder, current episode mixed
0.000 0.995 0.005
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.000 0.995 0.005
C50.8 Overlapping lesion of breast
0.005 0.995 0.000
F32.1 Moderate depressive episode
0.000 0.995 0.005
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.995 0.005
F32.2 Severe depressive episode without psychotic symptoms
0.000 0.995 0.005
K60.5 Anorectal fistula
0.005 0.995 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.000 0.995 0.005
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.000 0.995 0.005
M47.89 Other spondylosis (Site unspecified)
0.005 0.995 0.000
R47.8 Other and unspecified speech disturbances
0.000 0.995 0.005
F34 Persistent mood [affective] disorders
0.000 0.995 0.005
D69 Purpura and other haemorrhagic conditions
0.005 0.995 0.000
F52.2 Failure of genital response
0.000 0.995 0.005
F31.0 Bipolar affective disorder, current episode hypomanic
0.000 0.995 0.005
D04.6 Skin of upper limb, including shoulder
0.005 0.995 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.000 0.995 0.005
F11 Mental and behavioural disorders due to use of opioids
0.000 0.995 0.005
M79.60 Pain in limb (Multiple sites)
0.005 0.995 0.000
F33.8 Other recurrent depressive disorders
0.000 0.995 0.005
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.995 0.005
I30.9 Acute pericarditis, unspecified
0.000 0.995 0.005
F80-F89 Disorders of psychological development
0.000 0.995 0.005
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.000 0.995 0.005
F38 Other mood [affective] disorders
0.000 0.995 0.005
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.005 0.995 0.000
O75.2 Pyrexia during labour, not elsewhere classified
0.005 0.995 0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.000 0.995 0.005
K22.7 Barrett's oesophagus
0.005 0.995 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.995 0.005
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.000 0.995 0.005
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.000 0.995 0.004
F31.8 Other bipolar affective disorders
0.000 0.995 0.004
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.995 0.004
T51 Toxic effect of alcohol
0.000 0.995 0.004
F32.0 Mild depressive episode
0.000 0.996 0.004
F70-F79 Mental retardation
0.000 0.996 0.004
F60-F69 Disorders of adult personality and behaviour
0.000 0.996 0.004
F50 Eating disorders
0.000 0.996 0.004
Y91 Evidence of alcohol involvement determined by level of intoxication
0.004 0.996 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.000 0.996 0.004
F51 Nonorganic sleep disorders
0.000 0.996 0.004
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.996 0.004
F55 Abuse of non-dependence-producing substances
0.000 0.996 0.004
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.000 0.996 0.004
D69.2 Other nonthrombocytopenic purpura
0.004 0.996 0.000
F13.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F13.8 Other mental and behavioural disorders
0.000 0.996 0.004
F13.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F13.6 Amnesic syndrome
0.000 0.996 0.004
F13.5 Psychotic disorder
0.000 0.996 0.004
F13.4 Withdrawal state with delirium
0.000 0.996 0.004
F13.3 Withdrawal state
0.000 0.996 0.004
F13.2 Dependence syndrome
0.000 0.996 0.004
F13.1 Harmful use
0.000 0.996 0.004
F13.0 Acute intoxication
0.000 0.996 0.004
F14.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F14.8 Other mental and behavioural disorders
0.000 0.996 0.004
F14.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F14.6 Amnesic syndrome
0.000 0.996 0.004
F14.5 Psychotic disorder
0.000 0.996 0.004
F14.4 Withdrawal state with delirium
0.000 0.996 0.004
F14.3 Withdrawal state
0.000 0.996 0.004
F14.2 Dependence syndrome
0.000 0.996 0.004
F14.1 Harmful use
0.000 0.996 0.004
F14.0 Acute intoxication
0.000 0.996 0.004
F15.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F15.8 Other mental and behavioural disorders
0.000 0.996 0.004
F15.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F15.6 Amnesic syndrome
0.000 0.996 0.004
F15.5 Psychotic disorder
0.000 0.996 0.004
F15.4 Withdrawal state with delirium
0.000 0.996 0.004
F15.3 Withdrawal state
0.000 0.996 0.004
F15.2 Dependence syndrome
0.000 0.996 0.004
F15.1 Harmful use
0.000 0.996 0.004
F15.0 Acute intoxication
0.000 0.996 0.004
F16.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F16.8 Other mental and behavioural disorders
0.000 0.996 0.004
F16.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F16.6 Amnesic syndrome
0.000 0.996 0.004
F16.5 Psychotic disorder
0.000 0.996 0.004
F16.4 Withdrawal state with delirium
0.000 0.996 0.004
F16.3 Withdrawal state
0.000 0.996 0.004
F16.2 Dependence syndrome
0.000 0.996 0.004
F16.1 Harmful use
0.000 0.996 0.004
F16.0 Acute intoxication
0.000 0.996 0.004
F18.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F18.8 Other mental and behavioural disorders
0.000 0.996 0.004
F18.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F18.6 Amnesic syndrome
0.000 0.996 0.004
F18.5 Psychotic disorder
0.000 0.996 0.004
F18.4 Withdrawal state with delirium
0.000 0.996 0.004
F18.3 Withdrawal state
0.000 0.996 0.004
F18.2 Dependence syndrome
0.000 0.996 0.004
F18.1 Harmful use
0.000 0.996 0.004
F18.0 Acute intoxication
0.000 0.996 0.004
C50.0 Nipple and areola
0.004 0.996 0.000
F39 Unspecified mood [affective] disorder
0.000 0.996 0.004
K90.0 Coeliac disease
0.004 0.996 0.000
Y91.9 Alcohol involvement, not otherwise specified
0.004 0.996 0.000
F84 Pervasive developmental disorders
0.000 0.996 0.004
F34.1 Dysthymia
0.000 0.996 0.004
O68.9 Labour and delivery complicated by foetal stress, unspecified
0.004 0.996 0.000
M79.67 Pain in limb (Ankle and foot)
0.004 0.996 0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease
0.000 0.996 0.004
F52.8 Other sexual dysfunction, not caused by organic disorder or disease
0.000 0.996 0.004
F52.7 Excessive sexual drive
0.000 0.996 0.004
F52.6 Nonorganic dyspareunia
0.000 0.996 0.004
F52.5 Nonorganic vaginismus
0.000 0.996 0.004
F52.4 Premature ejaculation
0.000 0.996 0.004
F52.3 Orgasmic dysfunction
0.000 0.996 0.004
F52.1 Sexual aversion and lack of sexual enjoyment
0.000 0.996 0.004
F52.0 Lack or loss of sexual desire
0.000 0.996 0.004
F19.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F19.8 Other mental and behavioural disorders
0.000 0.996 0.004
F19.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F19.6 Amnesic syndrome
0.000 0.996 0.004
F19.5 Psychotic disorder
0.000 0.996 0.004
F19.4 Withdrawal state with delirium
0.000 0.996 0.004
F19.3 Withdrawal state
0.000 0.996 0.004
F19.2 Dependence syndrome
0.000 0.996 0.004
F19.0 Acute intoxication
0.000 0.996 0.004
L57.0 Actinic keratosis
0.000 0.996 0.004
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.004 0.996 0.000
F31.9 Bipolar affective disorder, unspecified
0.000 0.996 0.004
F81 Specific developmental disorders of scholastic skills
0.000 0.996 0.004
O68 Labour and delivery complicated by foetal stress [distress]
0.004 0.996 0.000
G82.2 Paraplegia, unspecified
0.004 0.996 0.000
D69.8 Other specified haemorrhagic conditions
0.004 0.996 0.000
D69.1 Qualitative platelet defects
0.004 0.996 0.000
F34.9 Persistent mood [affective] disorder, unspecified
0.000 0.996 0.004
F34.8 Other persistent mood [affective] disorders
0.000 0.996 0.004
F34.0 Cyclothymia
0.000 0.996 0.004
K60.4 Rectal fistula
0.004 0.996 0.000
F12.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F12.8 Other mental and behavioural disorders
0.000 0.996 0.004
F12.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F12.6 Amnesic syndrome
0.000 0.996 0.004
F12.5 Psychotic disorder
0.000 0.996 0.004
F12.4 Withdrawal state with delirium
0.000 0.996 0.004
F12.3 Withdrawal state
0.000 0.996 0.004
F12.0 Acute intoxication
0.000 0.996 0.004
F11.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F11.8 Other mental and behavioural disorders
0.000 0.996 0.004
F11.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F11.6 Amnesic syndrome
0.000 0.996 0.004
F11.5 Psychotic disorder
0.000 0.996 0.004
F11.4 Withdrawal state with delirium
0.000 0.996 0.004
F11.3 Withdrawal state
0.000 0.996 0.004
F11.0 Acute intoxication
0.000 0.996 0.004
D69.4 Other primary thrombocytopenia
0.004 0.996 0.000
F32.8 Other depressive episodes
0.000 0.996 0.004
I31.9 Disease of pericardium, unspecified
0.000 0.996 0.004
F31.7 Bipolar affective disorder, currently in remission
0.000 0.996 0.004
F89 Unspecified disorder of psychological development
0.000 0.996 0.004
F88 Other disorders of psychological development
0.000 0.996 0.004
F83 Mixed specific developmental disorders
0.000 0.996 0.004
F82 Specific developmental disorder of motor function
0.000 0.996 0.004
F38.8 Other specified mood [affective] disorders
0.000 0.996 0.003
F38.1 Other recurrent mood [affective] disorders
0.000 0.996 0.003
F38.0 Other single mood [affective] disorders
0.000 0.996 0.003
Y98 Lifestyle-related condition
0.004 0.996 0.000
Y97 Environmental-pollution-related condition
0.004 0.996 0.000
Y96 Work-related condition
0.004 0.996 0.000
F12.2 Dependence syndrome
0.000 0.996 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.